Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ:AMEX Investor Relations:
ir.eksobionics.com
Company Research
Source: GlobeNewswire
SAN RAFAEL, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that on October 28, 2025, it entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 769,490 shares of the Company’s common stock at a purchase price of $4.81 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about October 30, 2025, subject to the satisfaction of customary closing conditions. Lake Street Capital Markets, LLC is acting as the exclusive placement agent for the offering. The gross proceeds to the Company from the offering are expected to be $3.7 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering
Show less
Read more
Impact Snapshot
Event Time:
EKSO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EKSO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EKSO alerts
High impacting Ekso Bionics Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
EKSO
News
- Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch’s Groundbreaking BalanceTutor™ Rehabilitation SystemGlobeNewswire
- Ekso Bionics (NASDAQ:EKSO) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- How Recent Moves Are Rewriting the Story for Ekso Bionics [Yahoo! Finance]Yahoo! Finance
- Ekso Bionics (NASDAQ:EKSO) was given a new $6.00 price target on by analysts at HC Wainwright.MarketBeat
- Ekso Bionics (NASDAQ:EKSO) had its price target raised by analysts at HC Wainwright from $4.00 to $6.00. They now have a "buy" rating on the stock.MarketBeat
EKSO
Earnings
- 10/28/25 - Beat
EKSO
Sec Filings
- 11/12/25 - Form 4
- 11/12/25 - Form 4
- 11/12/25 - Form 4
- EKSO's page on the SEC website